24
Oct

GlaxoSmithKline, facing widespread scrutiny for its underperforming respiratory business, has expanded its relationship with Five Prime Therapeutics, digging in to discover new treatments in the field.

…read more

Source: GlaxoSmithKline cozies up to Five Prime for respiratory R&D

    

0 No comments